Anti-tumor activity of PM01183 (lurbinectedin) in BRCA1/2-associated metastatic breast cancer patients: results of a single-agent phase II trial

  1. Balmaña, J.
  2. Cruz, C.
  3. Arun, B.K.
  4. Telli, M.
  5. Garber, J.
  6. Domchek, S.
  7. Fernandez, C.M.
  8. Kahatt, C.
  9. Szyldergemajn, S.
  10. Soto-Matos, A.
  11. Haza, A.P.
  12. Fidalgo, J.A.P.
  13. Lluch-Hernandez, A.
  14. Antolin, S.
  15. Tung, N.M.
  16. Vahdat, L.T.
  17. Lopez, R.
  18. Isakoff, S.J.J.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2016

Alea: 27

Orrialdeak: vi68

Mota: Artikulua

DOI: 10.1093/ANNONC/MDW365.02 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus